Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Anthocyanins and Reduced Blood Cholesterol

Research synthesisLow evidenceMixed effect size4 studies · 2 beneficial · 2 neutral · 0 harmful

Across 4 studies, 2 reported beneficial effects on total cholesterol (one moderate, one small) while 2 found no significant effect. The median study duration was 112 days (16 weeks). The most common dose was 320 mg/day, but the only studies using that dose were neutral. Effect sizes are mixed (small to moderate).

  • Studied populations: Mixed populations (healthy adults and those with cardiometabolic diseases)

Caveats: Evidence is mixed: two large meta-analyses show beneficial effects on total cholesterol, but two clinical trials in specific populations (older adults with mild cognitive impairment, type 2 diabetes) found no significant effect. The beneficial meta-analysis reported high heterogeneity (I²=86.9%), indicating variability across studies. Only two studies reported duration, with a median of 112 days; longer-term effects are unclear. Most studies did not specify the form of anthocyanins, limiting dose-form conclusions.

Generated Jul 17, 2026
Doses used in studies
  • mg/day: 320 (median 320, IQR 320320) 3 studies
Time to effect
Median: 3.7 months · IQR 2.8 months4.7 months · Range 8 weeks5.6 months — Reported in 2 of 4 studies
4 of 4 papers
Back to top